BROWSE·page 163 of 605

Browse EX-10 agreements

7,253 matching material contract exhibits.


EXHIBIT 10.1

Apogee Therapeutics, Inc.


Exhibit 10.1

AGREEMENT REGARDING PARACHUTE PAYMENTS

THIS AGREEMENT REGARDING PARACHUTE PAYMENTS (this “Agreement”), dated as of [date], 2026 (the “Effective Date”), is made and entered into by and between Apogee Therapeutics, Inc., a Delaware corporation (the “Company”) and [name] (the “Individual” and together with the Company, the “Parties”).

WHEREAS, the Individual is employed by the Company and is a participant in the Apogee Therapeutics, Inc. Executive Severance Policy (the “Executive Severance Policy”);

WHEREAS, the Company is a party to that certain Agreement and Plan of Merger, dated June 18, 2026 (the “Merger Agreement”), by and among the Company, Andor LLC, a Delaware limited liability company, Andor Merger Co., a Delaware corporation and, solely for the limited purposes set forth therein, AbbVie Inc., a Delaware corporation (“AbbVie”) whereby the Company will be acquired by AbbVie (the “Transaction”); and

…

EX-10.1·8-K·CIK 1974640·ACC 0001140361-26-035537·Filed Sep 03, 2026, 08:53 ET

CONSENT UNDER

THIRD AMENDED AND RESTATED CREDIT AGREEMENT

** **

This CONSENT UNDER THIRD AMENDED AND RESTATED CREDIT AGREEMENT (this “Consent”) is entered into as of August 31, 2026 by and among HF FOODS GROUP INC., a Delaware corporation (“HF”), B&R GLOBAL HOLDINGS, INC., a Delaware corporation (“B&R”), RONGCHENG TRADING, LLC, a California limited liability company (“Rongcheng”), CAPITAL TRADING, LLC, a Utah limited liability company (“Capital”), WIN WOO TRADING, LLC, a California limited liability company (“Win Woo”), R & C TRADING L.L.C., an Arizona limited liability company (“R & C”), GREAT WALL SEAFOOD LA, LLC, a California limited liability company (“Great Wall”), B & L TRADING, LLC, a Washington limited liability company (“B & L”), MOUNTAIN FOOD, LLC, a Colorado limited liability company (“Mountain”), MIN FOOD INC., a California corporation (“Min Food”), MONTEREY FOOD SERVICE, LLC, a California limited liability company (“Monterey”), HAN FENG, INC., a North Carolina corporation (“Han Feng”), NEW SOUTHERN FOOD DISTRIBUTORS, INC., a Florida cor

…

EX-10.3·8-K·CIK 1680873·ACC 0001213900-26-096950·Filed Sep 03, 2026, 08:46 ET

Certain portions of this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(10)(iv) because they are both (i) not material to investors and (ii) the type of information that the Company customarily and actually treats as private or confidential, and have been marked with “[***]” to indicate where omissions have been made. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the SEC upon its request.

AMENDMENT TO SECURITIES PURCHASE AGREEMENT

…

EX-10.2·8-K·CIK 1680873·ACC 0001213900-26-096950·Filed Sep 03, 2026, 08:46 ET

EX-10.1

Aimei Health Technology Co., Ltd.

** **

Exhibit 10.1

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

PROMISSORY NOTE

Principal Amount: US$34,330.96

Dated: September 3, 2026

…

EX-10.1·8-K·CIK 1979005·ACC 0001493152-26-041316·Filed Sep 03, 2026, 08:00 ET

EXHIBIT 10.1

Medicus Pharma Ltd.


CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

CONFIDENTIAL Pfizer Inc. to Medicus Subject Matter: CD228V Execution Copy

CO-DEVELOPMENT AND LICENSE AGREEMENT

THIS CO-DEVELOPMENT AND LICENSE AGREEMENT ("Agreement") is made effective as of September 2, 2026 (the "Effective Date"), by and between Medicus Pharma Inc. a Delaware corporation with offices at 300 Conshohocken State Rd Suite 200 W Conshohocken PA 19428 ("Licensee") and Pfizer Inc., a Delaware corporation, with offices at 66 Hudson Blvd. East, New York, NY 10001 ("Pfizer"). Licensee and Pfizer may, from time-to-time, be individually referred to as a "Party" and collectively referred to as the "Parties".

RECITALS

…

EX-10.1·8-K·CIK 1997296·ACC 0001062993-26-004806·Filed Sep 03, 2026, 08:00 ET

EX-10.1

EQUITY BANCSHARES INC

***FORM OF ***

***VOTING AGREEMENT ***

This VOTING AGREEMENT (this “Agreement”) dated as of September 2, 2026 is executed by and among Equity Bancshares, Inc. (“EQBK”), a Kansas corporation and registered bank holding company under the Bank Holding Company Act of 1956, as amended (the “BHCA”), Lincoln Bancorp (“Lincoln”), an Iowa corporation and registered bank holding company under the BHCA, Brad S. Elliott (“Proxy Holder”), as proxy, and the shareholders of Lincoln listed on the signature page to this Agreement (referred to herein individually as a “Shareholder” and collectively with the other Lincoln shareholders entering into this Agreement, as the “Shareholders”). Terms with their initial letters capitalized and not otherwise defined herein have the meanings given them in the Reorganization Agreement (as defined below).

***RECITALS ***

…

EX-10.1·8-K·CIK 1227500·ACC 0001193125-26-381051·Filed Sep 03, 2026, 07:46 ET

EX-10.2

EQUITY BANCSHARES INC

***FORM OF ***

***DIRECTOR SUPPORT AGREEMENT ***

This DIRECTOR SUPPORT AGREEMENT (the “Agreement”) is made and entered into as of September 2, 2026, by and between Equity Bancshares, Inc. (“EQBK”), a Kansas corporation and registered bank holding company under the Bank Holding Company Act of 1956, as amended (the “BHCA”), and [_____________], an individual resident of the State of [____] (“Director”). Terms with their initial letters capitalized and not otherwise defined herein have the meanings given to them in the Reorganization Agreement (as defined below).

***RECITALS ***

…

EX-10.2·8-K·CIK 1227500·ACC 0001193125-26-381051·Filed Sep 03, 2026, 07:46 ET

EX-10.1

Hillman Solutions Corp.

AMENDMENT NO. 1 TO CREDIT AGREEMENT

This AMENDMENT NO. 1 TO CREDIT AGREEMENT (this “Amendment”), dated as of August 28, 2026, is made by and among THE HILLMAN GROUP, INC., a Delaware corporation (the “Borrower”), THE HILLMAN COMPANIES, INC., a Delaware corporation (“Holdings”), JEFFERIES FINANCE LLC (“Jefferies”), as administrative agent and collateral agent under the Existing Credit Agreement (as defined below) (in such capacity, the “Administrative Agent”) and the undersigned 2026 Incremental Term Lenders (as defined below).

WHEREAS, Holdings, the Borrower, the Administrative Agent and the other signatories party thereto from time to time are party to that certain Credit Agreement, dated as of July 22, 2026 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Existing Credit Agreement”);

…

EX-10.1·8-K·CIK 1822492·ACC 0001822492-26-000144·Filed Sep 03, 2026, 07:45 ET

FORM OF NON-REDEMPTION AGREEMENT

Crown PropTech Acquisitions

NON-REDEMPTION AGREEMENT

This Non-Redemption Agreement (this “Agreement”) is entered as of September __, 2026 by and among Crown PropTech Acquisitions (“CPTK”), CIIG III Management LLC (the “Sponsor”), Crown PropTech Sponsor, LLC (the “Original Sponsor”) and the undersigned investor (“Investor”).

RECITALS

** **

WHEREAS, the Sponsor currently holds 5,662,000 Class B ordinary shares, par value $0.0001 per share of CPTK (the “Class B Ordinary Shares,” and the Class B Ordinary Shares held by the Sponsor, the “Founder Shares”) of which an aggregate of [__________]1 as of the date hereof are Assigned Securities (as defined in each of the February 2023 NRA, the February 2024 NRA, the August 2024 NRA, the May 2025 NRA and the March 2026 (as defined below)) in connection with five previously executed non-redemption agreements with the Investor relating to the applicable charter amendment extension proposal at the applicable Company extraordinary general meeting held on (i) February 9, 2023 (the “February 2023 NRA”), (ii) February 9, 2024 (the “*February 2024

…

EX-10.2·8-K·CIK 1827899·ACC 0001213900-26-096929·Filed Sep 03, 2026, 07:30 ET

amendMENT No. 1

to THE

SPONSOR SUPPORT AGREEMENT

______________

This AMENDMENT NO. 1 (this “Amendment”), dated as of September 2, 2026, amends the Sponsor Support Agreement, dated as of July 2, 2025 (as amended and including all exhibits and schedules thereto, the “Sponsor Support Agreement”), by and among (i) Crown PropTech Acquisitions (“SPAC”), (ii) CIIG Management III LLC, a Delaware limited liability company (“Sponsor”), (iii) the undersigned investors in SPAC (the “Investors”, and together with Sponsor, the “SPAC Holders”), (iv) Lancaster Exploration Limited, a company incorporated under the laws of the British Virgin Islands (“Lancaster BVI”, and from and after the Closing, “PubCo”), (v)  Mkango Polska s.p. Z.o.o., a company organized under the laws of Poland (“MKA Poland”), (vi) Mkango ServiceCo UK Limited, a company organized under the laws of England (“Mkango ServiceCo”), and (vii) MKA Exploration Limited, a company incorporated under the laws of the British Virgin Islands (“MKA BVI”, and together with Lancaster BVI, MKA Poland an

…

EX-10.1·8-K·CIK 1827899·ACC 0001213900-26-096929·Filed Sep 03, 2026, 07:30 ET

EXHIBIT 10.4

Texas Ventures Acquisition III Corp

SUBSCRIPTION AGREEMENT

This Subscription Agreement (this “Subscription Agreement”) is being entered into as of the date set forth on the signature page to this Subscription Agreement, by and among Texas Ventures Acquisition III Corp, a Cayman Islands exempted company limited by shares (the “Issuer”, which after the date of the Domestication, shall be known as PlusAI Holdings, Inc., a Delaware corporation), Plus Automation, Inc., a Delaware corporation (the “Company”), and the undersigned (the “Investor”). The Subscription Agreement is entered into in connection with the Agreement and Plan of Merger and Reorganization, dated September 2, 2026 (as may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among the Issuer, the Company and the other parties thereto. The transactions contemplated by the Merger Agreement are referred to in this Subscription Agreement as the “Transaction” and the purchase and sale of the Securities (as defined below) pursuant to this Subscription Agreement are referred to in this Subscription Agre

…

EX-10.4·8-K·CIK 2033991·ACC 0001104659-26-104858·Filed Sep 02, 2026, 21:45 ET

EXHIBIT 10.5

Texas Ventures Acquisition III Corp

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (as it may be amended, supplemented or restated from time to time in accordance with its terms, this “A&R Registration Rights Agreement”), dated as of September 2, 2026 is made and entered into by and among (i) PLUSAI HOLDINGS, INC. (f/k/a TEXAS VENTURES ACQUISITION III CORP), a Delaware corporation (the “PubCo”); (ii) each of the Persons identified on the signature pages hereto or on the signature pages to a joinder in the form attached to this A&R Registration Rights Agreement as Exhibit A under the heading “Company Shareholders” or “Insiders”; (iii) YORKVILLE ACQUISITION SPONSOR II, a Delaware limited liability company (the “Sponsor”), and its Affiliate, YA II PN, LTD. (“Sponsor Affiliate”); (iv) COHEN & COMPANY CAPITAL MARKETS, a division of Cohen & Company Securities, LLC (f/k/a Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC) (“CCM”); and (v) CLEAR STREET LLC (“Clear Street,” together with CCM, the “*Rep

…

EX-10.5·8-K·CIK 2033991·ACC 0001104659-26-104858·Filed Sep 02, 2026, 21:45 ET